Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7988)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2020 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rajbhandari R, Blakemore S, Gupta N, Adler AJ, Noble CA, Mannan S, Nikolli K, Yih A, Joshi S, Bukhman G. Crohn’s disease in low and lower-middle income countries: A scoping review. World J Gastroenterol 2020; 26(43): 6891-6908 [PMID: 33268969 DOI: 10.3748/wjg.v26.i43.6891] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i43/6891.htm |
| Number | Citing Articles |
| 1 |
Mostafa Abd Alfattah Shamkh, Mohamed Amin Sakr, Waleed Hamed Abd Alaty, Shimaa Youssef Kamel, Mohamed Mahmoud Eltabbakh, Ahmed Fouad Sherief, Heba Rashad, Safaa Askar. A decade of inflammatory bowel disease: a single center experience in Egypt. The Egyptian Journal of Internal Medicine 2022; 34(1) doi: 10.1186/s43162-022-00115-x
|
| 2 |
Ruma Rajbhandari, Samantha Blakemore, Neil Gupta, Sara Mannan, Klejda Nikolli, Alison Yih, Laura Drown, Gene Bukhman. Crohn’s Disease Among the Poorest Billion: Burden of Crohn’s Disease in Low- and Lower-Middle-Income Countries. Digestive Diseases and Sciences 2023; 68(4): 1226 doi: 10.1007/s10620-022-07675-6
|
| 3 |
Zvonimir Petric, Joao Goncalves, Paulo Paixao. Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars. Pharmaceutics 2022; 14(9): 1766 doi: 10.3390/pharmaceutics14091766
|
| 4 |
Othman Alharbi, Waleed Hamed, Osama Salem, Catherine Taylor, Ahmed Besar, Mohamed Sharaf. Exploring treatment of inflammatory bowel disease with infliximab in the Middle East and Northern Africa: An analysis of the HARIR observational cohort study. Saudi Journal of Gastroenterology 2023; 29(3): 164 doi: 10.4103/sjg.sjg_434_22
|
| 5 |
Xijing Huang, Yan Pan, Ya Liu, Zhou Zhou, Yinghui Zhang, Caiping Gao, Chong He. Clinical Utility of the Neutrophil-to-Bilirubin Ratio in the Detection of Disease Activity in Ulcerative Colitis. Journal of Inflammation Research 2023; : 2549 doi: 10.2147/JIR.S413644
|
| 6 |
Blake O. Langley, Sara E. Guedry, Joshua Z. Goldenberg, Douglas A. Hanes, Jennifer A. Beardsley, Jennifer Joan Ryan. Inflammatory Bowel Disease and Neutrophil–Lymphocyte Ratio: A Systematic Scoping Review. Journal of Clinical Medicine 2021; 10(18): 4219 doi: 10.3390/jcm10184219
|
| 7 |
Kristian Espeland, Andrius Kleinauskas, Petras Juzenas, Sagar Darvekar, Vlada Vasovic, Trond Warloe, Eidi Christensen, Jørgen Jahnsen, Qian Peng. Photodynamic Effects with 5-Aminolevulinic Acid on Cytokines and Exosomes in Human Peripheral Blood Mononuclear Cells from Patients with Crohn’s Disease. International Journal of Molecular Sciences 2023; 24(5): 4554 doi: 10.3390/ijms24054554
|
| 8 |
Runing Zhou, Ruixian Wu, Li Wang, Hong Yang. Increasing ratio of opportunistic infections associated with sunshine exposure and economic level burdening Chinese inflammatory bowel disease hospitalized patients: the first nationwide survey from 2014 to 2019. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-17635-6
|
| 9 |
Tayyab Saeed Akhtar, Bilal Ashraf, Kanza Zahid, Sameen Abbas, Anosh Sana, Abdul Rauf Khan, Faiqa Ijaz, Faisal Riaz. Evaluation of Factors Contributing to Diagnosis of Crohn’s Disease in the Face of Increasing Trend in Pakistan. Crohn's & Colitis 360 2024; 6(1) doi: 10.1093/crocol/otae015
|
| 10 |
Gillian Watermeyer, Yaw Awuku, Ernst Fredericks, David Epstein, Mashiko Setshedi, Smita Devani, Wisdom Mudombi, Chris Kassianides, Leolin Katsidzira. Challenges in the management of inflammatory bowel disease in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 2022; 7(10): 962 doi: 10.1016/S2468-1253(22)00048-6
|
| 11 |
Zhou Zhou, Yinghui Zhang, Yan Pan, Xue Yang, Liangping Li, Caiping Gao, Chong He. A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.872831
|
| 12 |
Daisy Carolina Huertas Martinez, Guilherme Andrade Bulbol, Poliana Corrêa Moreira Braga, Moisés Abtibol Machado. AVALIAÇÃO CLÍNICA DA DOENÇA DE CROHN COM SOBREPOSIÇÃO À HEPATITE AUTOIMUNE: RELATO DE CASO. Revista Contemporânea 2024; 4(1): 4934 doi: 10.56083/RCV4N1-271
|
| 13 |
Asha Jois, George Alex. Inflammatory Bowel Disease in Children. Indian Journal of Pediatrics 2024; 91(5): 490 doi: 10.1007/s12098-023-04671-0
|
| 14 |
Nishani Jayasooriya, Samantha Baillie, Jonathan Blackwell, Alex Bottle, Irene Petersen, Hanna Creese, Sonia Saxena, Richard C. Pollok. Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2023; 57(6): 635 doi: 10.1111/apt.17370
|
| 15 |
Kathryn M. Chu, Lynn Bust, Tim Forgan. Colorectal Surgery Practice, Training, and Research in Low-Resource Settings. Clinics in Colon and Rectal Surgery 2022; 35(05): 410 doi: 10.1055/s-0042-1746190
|
| 16 |
Jonathan Y. Xia, Chelsea Hepler, Peter Tran, Nathan J. Waldeck, Joseph Bass, Arthur Prindle. Engineered calprotectin-sensing probiotics for IBD surveillance in humans. Proceedings of the National Academy of Sciences 2023; 120(32) doi: 10.1073/pnas.2221121120
|
| 17 |
Emmanuel T. Limpin, Marc Paul J. Lopez, Sittie Aneza Camille A. Maglangit, Joshua Josef R. Torres, Mark Augustine S. Onglao, Ma Corazon Cabanilla-Manuntag, Ruter M. Maralit, Rodney B. Dofitas. Surgical Management of Patients With GI Tuberculosis. Diseases of the Colon & Rectum 2023; 66(1): 106 doi: 10.1097/DCR.0000000000002626
|